+Search query
-Structure paper
| Title | Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy. |
|---|---|
| Journal, issue, pages | Nat Cardiovasc Res, Vol. 3, Page 1003-1016, Year 2024 |
| Publish date | May 1, 2024 (structure data deposition date) |
Authors | Hartman, J.J. / Hwee, D.T. / Robert-Paganin, J. / Chuang, C. / Chin, E.R. / Edell, S. / Lee, K.H. / Madhvani, R. / Paliwal, P. / Pernier, J. ...Hartman, J.J. / Hwee, D.T. / Robert-Paganin, J. / Chuang, C. / Chin, E.R. / Edell, S. / Lee, K.H. / Madhvani, R. / Paliwal, P. / Pernier, J. / Sarkar, S.S. / Schaletzky, J. / Schauer, K. / Taheri, K.D. / Wang, J. / Wehri, E. / Wu, Y. / Houdusse, A. / Morgan, B.P. / Malik, F.I. |
External links | Nat Cardiovasc Res / PubMed:39196032 |
| Methods | X-ray diffraction |
| Resolution | 2.33 Å |
| Structure data | ![]() PDB-9f6c: |
| Chemicals | ![]() ChemComp-SO4: ![]() ChemComp-MG: ![]()
ChemComp-6I6: ![]() ChemComp-ADP: ![]() ChemComp-VO4: ![]() ChemComp-HOH: |
| Source |
|
Keywords | MOTOR PROTEIN / cardiac myosin / modulator / cardiomyopathy / force production |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links







Keywords